100 Recruiting Studies Using Irinotecan
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Irinotecan
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer
📍 OHSU Knight Cancer Institute — Portland, Oregon
Pancreatic Adenocarcinoma
View Study & Checklist ➔Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
📍 University of Florida Proton Therapy Institute — Jacksonville, Florida
Rhabdomyosarcoma
View Study & Checklist ➔A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)
📍 Banner MD Anderson Cancer Center ( Site 0119) — Gilbert, Arizona
Gastroesophageal Cancer
View Study & Checklist ➔Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
📍 Memorial Sloan Kettering Cancer Center — Basking Ridge, New Jersey
Colorectal Cancer
View Study & Checklist ➔A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
📍 HonorHealth Research Institute — Scottsdale, Arizona
Solid Tumor
View Study & Checklist ➔Study of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal Cancer
📍 Sunnybrook Odette Cancer Centre — Toronto, Ontario
Metastatic Colorectal Cancer
View Study & Checklist ➔Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Sarcoma
View Study & Checklist ➔A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)
📍 Local Institution - 0059 — Los Angeles, California
Metastatic Colorectal Cancer
View Study & Checklist ➔Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors
📍 University of Alabama at Birmingham/Children's of Alabama — Birmingham, Alabama
Ewing Sarcoma
View Study & Checklist ➔A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
📍 Cohen Children's Medical Center of New York — New Hyde Park, New York
Pilomyxoid Astrocytoma
View Study & Checklist ➔Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Locally Advanced Rectal Carcinoma
View Study & Checklist ➔Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
Pancreatic Cancer
View Study & Checklist ➔Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
Metastatic Lung Small Cell Carcinoma
View Study & Checklist ➔Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Advanced Colorectal Carcinoma
View Study & Checklist ➔A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
📍 Mayo Clinic Hospital — Phoenix, Arizona
Neoplasms
View Study & Checklist ➔Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.
📍 University of California LA — Los Angeles, California
MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers
View Study & Checklist ➔Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Alveolar Rhabdomyosarcoma
View Study & Checklist ➔Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Clinical Stage III Gastric Cancer AJCC v8
View Study & Checklist ➔A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
📍 Summit Therapeutics Research Site — Los Angeles, California
Metastatic Colorectal Cancer
View Study & Checklist ➔Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors
📍 University of California Los Angeles UCLA - Cancer Care - Santa Monica — Santa Monica, California
Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer
View Study & Checklist ➔Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Colorectal Adenocarcinoma
View Study & Checklist ➔Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Sarcoma
View Study & Checklist ➔Study of Chemoimmunotherapy for High-Risk Neuroblastoma
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Neuroblastoma (NB)
View Study & Checklist ➔Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)
📍 Banner Children's at Desert — Mesa, Arizona
Ganglioneuroblastoma, Nodular
View Study & Checklist ➔Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer
📍 Mayo Clinic in Rochester — Rochester, Minnesota
Locally Advanced Pancreatic Adenocarcinoma
View Study & Checklist ➔Phase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal Cancer
📍 M D Anderson Cancer Center — Houston, Texas
Colon Cancer
View Study & Checklist ➔Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and Bevacizumab
📍 Mayo Clinic Arizona /ID# 262610 — Phoenix, Arizona
Unresectable Metastatic Colorectal Cancer
View Study & Checklist ➔Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer
📍 Chan Soon-Shiong Institute for Medicine — El Segundo, California
Pancreatic Cancer
View Study & Checklist ➔Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
📍 City of Hope Medical Center — Duarte, California
Recurrent Anaplastic Astrocytoma
View Study & Checklist ➔Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
📍 Children's Hospital of Alabama — Birmingham, Alabama
Childhood Hepatocellular Carcinoma
View Study & Checklist ➔131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma
📍 Children's Hospital Los Angeles — Los Angeles, California
Recurrent Medulloblastoma
View Study & Checklist ➔CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma
📍 Phoenix Children's Hospital — Phoenix, Arizona
Sarcoma, Ewing
View Study & Checklist ➔Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
High Risk Neuroblastoma
View Study & Checklist ➔9-ING-41 in Patients With Advanced Cancers
📍 Mayo Clinic — Phoenix, Arizona
Cancer
View Study & Checklist ➔Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer
📍 Sidney Kimmel Cancer Center at Thomas Jefferson University — Philadelphia, Pennsylvania
Locally Advanced Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body
📍 Children's Hospital of Alabama — Birmingham, Alabama
CIC-Rearranged Sarcoma
View Study & Checklist ➔AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
📍 Research Site — Mobile, Alabama
Gastric Cancer
View Study & Checklist ➔Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC
📍 University of Wisconsin Carbone Cancer Center — Madison, Wisconsin
Metastatic Colorectal Cancer
View Study & Checklist ➔Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma
📍 Memorial Sloan Kettering Cancer Center Basking Ridge — Basking Ridge, New Jersey
Newly Diagnosed Ewing Sarcoma
View Study & Checklist ➔Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.
📍 Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland
Metastatic Pancreatic Cancer
View Study & Checklist ➔PhII ICb With/Without Erbitux in MBC Pts
📍 Birmingham Hematology and Oncology — Birmingham, Alabama
Metastatic Breast Cancer
View Study & Checklist ➔A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
📍 University of Alabama at Birmingham — Birmingham, Alabama
Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
📍 Los Angeles General Medical Center — Los Angeles, California
Metastatic Colorectal Carcinoma
View Study & Checklist ➔Erlotinib Hydrochloride and Irinotecan Hydrochloride in Treating Patients With Advanced Solid Tumors
📍 Mayo Clinic in Rochester — Rochester, Minnesota
Adult Solid Neoplasm
View Study & Checklist ➔EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer
📍 Roswell Park Comprehensive Cancer Center — Buffalo, New York
Colo-rectal Cancer
View Study & Checklist ➔A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
📍 USA Mitchell Cancer Institute-Clinical Trials ( Site 4126) — Mobile, Alabama
Cervical Cancer
View Study & Checklist ➔Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer
📍 Mayo Clinic in Arizona — Scottsdale, Arizona
BRAF V600E Negative
View Study & Checklist ➔Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Pancreatic Adenosquamous Carcinoma
View Study & Checklist ➔DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
Borderline Resectable Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔SMAD4 Tailored Neoadjuvant Therapy for the Treatment of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma, SMART-PANC Trial
📍 Northwestern University — Chicago, Illinois
Borderline Resectable Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal Cancer
📍 City of Hope Medical Center — Duarte, California
Advanced Microsatellite Stable Colorectal Carcinoma
View Study & Checklist ➔Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial
📍 CTCA at Western Regional Medical Center — Goodyear, Arizona
Metastatic Appendix Carcinoma
View Study & Checklist ➔Tovecimig Plus FOLFIRI in Second Line Metastatic Colorectal Cancer
📍 Washington University School of Medicine — St Louis, Missouri
Colorectal Cancer
View Study & Checklist ➔N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
📍 Memorial Sloan Kettering Cancer Center — New York, New York
High-risk Neuroblastoma
View Study & Checklist ➔A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
📍 Children's Hospital of Alabama — Birmingham, Alabama
Anaplastic Kidney Wilms Tumor
View Study & Checklist ➔Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
📍 The University of Arizona Cancer Center-North Campus — Tucson, Arizona
Pancreatic Cancer
View Study & Checklist ➔Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)
📍 Washington University School of Medicine — St Louis, Missouri
Small-cell Lung Cancer
View Study & Checklist ➔Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Metastatic Colorectal Carcinoma
View Study & Checklist ➔Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease
📍 University of California, San Francisco — San Francisco, California
Medulloblastoma
View Study & Checklist ➔NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial
📍 Roswell Park Cancer Institute — Buffalo, New York
Borderline Resectable Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
📍 City of Hope Medical Center — Duarte, California
Clinical Stage IV Gastric Cancer AJCC v8
View Study & Checklist ➔A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
📍 University of Arizona Cancer Center-University of Arizona Cancer Center ( Site 4927) — Tucson, Arizona
Esophageal Squamous Cell Carcinoma
View Study & Checklist ➔A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
📍 Children's Hospital of Alabama — Birmingham, Alabama
Stage I Mixed Cell Type Kidney Wilms Tumor
View Study & Checklist ➔A Study of ASP1002 in Adults for Treatment of Solid Tumors
📍 Yale University Cancer Center — New Haven, Connecticut
Advanced Solid Tumors
View Study & Checklist ➔Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
📍 Investigative Site #132 — Phoenix, Arizona
Advanced Solid Tumor
View Study & Checklist ➔GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
📍 University of Kentucky — Lexington, Kentucky
Colorectal Cancer
View Study & Checklist ➔A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
📍 City of Hope (City of Hope National Medical Center, City of Hope Medical Center) — Duarte, California
Small Cell Lung Cancer (SCLC)
View Study & Checklist ➔Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas
📍 Chao Family Comprehensive Cancer Center, University of California, Irvine — Orange, California
Colon Adenocarcinoma
View Study & Checklist ➔Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Metastatic Small Intestinal Adenocarcinoma
View Study & Checklist ➔A Study of ASP3082 in Adults With Advanced Solid Tumors
📍 City of Hope National Medical Center — Duarte, California
Solid Tumor
View Study & Checklist ➔A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
📍 Children's Hospital of Alabama — Birmingham, Alabama
Rhabdomyosarcoma
View Study & Checklist ➔Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
📍 John Hunter Children's Hospital — Newcastle, New South Wales
Childhood Cancer
View Study & Checklist ➔A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
📍 University of California Irvine Medical Center — Orange, California
Gastric Adenocarcinoma
View Study & Checklist ➔mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Advanced Esophageal Adenocarcinoma
View Study & Checklist ➔A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
Colorectal Neoplasms
View Study & Checklist ➔Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Neuroblastoma
View Study & Checklist ➔A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
📍 Childrens Hospital of Alabama — Birmingham, Alabama
Neoplasms
View Study & Checklist ➔Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
📍 HonorHealth Research Institute — Scottsdale, Arizona
Ewing Sarcoma
View Study & Checklist ➔Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
📍 M D Anderson Cancer Center — Houston, Texas
Metastatic Sarcoma
View Study & Checklist ➔SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer
📍 University of Miami — Miami, Florida
Locally Advanced Rectal Cancer
View Study & Checklist ➔Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Locally Advanced Pancreatic Adenocarcinoma
View Study & Checklist ➔AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
📍 Research Site — Orange, California
Gastric Cancer
View Study & Checklist ➔A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors
📍 M D Anderson Cancer Center — Houston, Texas
Refractory Solid Tumors
View Study & Checklist ➔Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Ganglioneuroblastoma, Nodular
View Study & Checklist ➔Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
📍 Boston Children's Hospital — Boston, Massachusetts
Neuroblastoma
View Study & Checklist ➔ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver Metastases
📍 M D Anderson Cancer Center — Houston, Texas
Liver Metastases
View Study & Checklist ➔NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
📍 Children's Hospital Los Angeles — Los Angeles, California
Neuroblastoma
View Study & Checklist ➔MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
📍 City of Hope — Duarte, California
Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
📍 START Los Angeles, LLC — Los Angeles, California
Advanced Solid Tumors
View Study & Checklist ➔AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma
📍 University of Florida — Gainesville, Florida
Hepatocellular Carcinoma
View Study & Checklist ➔A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
📍 Mayo Clinic Hospital — Phoenix, Arizona
Esophageal Squamous Cell Carcinoma
View Study & Checklist ➔Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
📍 Yonemoto,Lisa — Los Angeles, California
Borderline Resectable Pancreatic Adenocarcinoma
View Study & Checklist ➔A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
📍 University of California San Francisco — San Francisco, California
Neuroblastoma Recurrent
View Study & Checklist ➔Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
📍 University of Alabama at Birmingham (Children's of Alabama) — Birmingham, Alabama
Metastatic Ewing Sarcoma
View Study & Checklist ➔A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
📍 Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York
Advanced Cancer
View Study & Checklist ➔A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer
📍 Massachusetts General Hospital — Boston, Massachusetts
Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
📍 University of Alabama at Birmingham — Birmingham, Alabama
Advanced Cancer
View Study & Checklist ➔Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
📍 University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina
Pancreatic Ductal Adenocarcinoma (PDAC)
View Study & Checklist ➔A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma
📍 University of Chicago Medical Center /ID# 279460 — Chicago, Illinois
Metastatic Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies
📍 The University of Chicago — Chicago, Illinois
Pancreatic Adenocarcinoma
View Study & Checklist ➔